Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza A matrix protein 1 (M1) is a multifunctional structural component essential for influenza virus replication. It orchestrates key steps such as particle assembly/budding by forming an endoskeletal layer under the lipid envelope while mediating interactions among various viral components—including glycoproteins on the surface and internal ribonucleoproteins—and regulating processes like nuclear export through post-translational modifications such as phosphorylation. Its highly ordered structure makes it vital not only to virion stability but also to potential antiviral strategies targeting its unique interfaces or regulatory mechanisms.
Inhibition of M1 oligomerization/assembly (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza A Matrix Protein 1 (M1).